These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparative immunogenicity of hepatitis B virus core and E antigens. Milich DR, McLachlan A, Stahl S, Wingfield P, Thornton GB, Hughes JL, Jones JE. J Immunol; 1988 Nov 15; 141(10):3617-24. PubMed ID: 2460543 [Abstract] [Full Text] [Related]
5. In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. Tsutsumi Y, Kakumu S, Wakita T, Yoshioka K, Ishikawa T. J Immunol; 1990 Mar 15; 144(6):2389-93. PubMed ID: 2313098 [Abstract] [Full Text] [Related]
6. H-2(d) mice born to and reared by HBeAg-transgenic mothers do not develop T cell tolerance toward the hepatitis B virus core gene products. Merkle H, Deutschle T, Gastrock-Balitsch I, Nusser P, Knehr S, Reifenberg K. Virology; 2000 Jul 20; 273(1):149-59. PubMed ID: 10891417 [Abstract] [Full Text] [Related]
7. Immune tolerance split between hepatitis B virus precore and core proteins. Chen M, Sällberg M, Hughes J, Jones J, Guidotti LG, Chisari FV, Billaud JN, Milich DR. J Virol; 2005 Mar 20; 79(5):3016-27. PubMed ID: 15709022 [Abstract] [Full Text] [Related]
8. Characterization of T-cell tolerance to hepatitis B virus (HBV) antigen in transgenic mice. Takashima H, Araki K, Miyazaki J, Yamamura K, Kimoto M. Immunology; 1992 Mar 20; 75(3):398-405. PubMed ID: 1533387 [Abstract] [Full Text] [Related]
12. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits. Isaguliants MG, Kadoshnikov YP, Kalinina TI, Smirnov VD, Wahren B. Biochemistry (Mosc); 1998 May 20; 63(5):551-8. PubMed ID: 9632891 [Abstract] [Full Text] [Related]
13. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. Waldner H, Sobel RA, Howard E, Kuchroo VK. J Immunol; 1997 Oct 01; 159(7):3100-3. PubMed ID: 9317104 [Abstract] [Full Text] [Related]
14. Hepatitis B virus e antigen specific epitopes and limitations of commercial anti-HBe immunoassays. Baumeister MA, Medina-Selby A, Coit D, Nguyen S, George-Nascimento C, Gyenes A, Valenzuela P, Kuo G, Chien DY. J Med Virol; 2000 Mar 01; 60(3):256-63. PubMed ID: 10630956 [Abstract] [Full Text] [Related]
16. Influence of T-helper cell subsets and crossregulation in hepatitis B virus infection. Milich DR. J Viral Hepat; 1997 Mar 01; 4 Suppl 2():48-59. PubMed ID: 9429210 [Abstract] [Full Text] [Related]
17. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis. Dittel BN, Merchant RM, Janeway CA. J Immunol; 1999 Jun 01; 162(11):6392-400. PubMed ID: 10352252 [Abstract] [Full Text] [Related]
19. Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg. Milich DR, McLachlan A, Moriarty A, Thornton GB. J Immunol; 1987 Aug 15; 139(4):1223-31. PubMed ID: 2440947 [Abstract] [Full Text] [Related]
20. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region. Maruyama T, Mitsui H, Maekawa H, Yamada H, Hirayama M, Iino S, Yasuda K, Koike K, Kimura S, Milich DR. Am J Gastroenterol; 2000 Oct 15; 95(10):2894-904. PubMed ID: 11051365 [Abstract] [Full Text] [Related] Page: [Next] [New Search]